Regulatory guidelines from the Medicines and Healthcare products Regulatory Agency state that only people classified as clinically obese, with a Body Mass Index (BMI) of more than 30, or those who are overweight (BMI of 27-30) with at least one weight-related health condition such as high blood pressure or type 2 diabetes, will be eligible to receive the drug
Carthew RW, Sontheimer EJ
This mechanism is dose-dependent, meaning higher doses typically produce stronger gastrointestinal effects during the first two to four weeks of treatment
Strategic Narrative Mapping:We go beyond the mechanism of action, centering storytelling in meaningful patient transformation and physician impact
doi:10.1016/j.biomaterials.2025.122256
This compound, derived from angiotensin IV, has been shown to possess a wide range of biological activities, including enhancing cognitive function, promoting neurogenesis, and potentially mitigating the effects of neurodegenerative diseases